Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Author:

Zhang You,Gao Chuanyu,Liu Hongzhi¹,Wang Xianpei¹,Yang Honghui¹,Li Muwei¹,Wang Xianqing¹,Zhu Zhongyu¹,Hu Dayi²

Affiliation:

1. Department of Cardiology; Zhengzhou University People's Hospital; Zhengzhou; China

2. Beijing University People's Hospital; Beijing; China

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

Reference25 articles.

1. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina;Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators;N. Engl. J. Med.,1998

2. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes;Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators;N. Engl. J. Med.,1998

4. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction;Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators;N. Engl. J. Med.,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献